 |
|
Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose DependencyA Meta-analysis of Randomized Controlled Trials
Heike A. Bischoff-Ferrari, DrPH;
Walter C. Willett, DrPH;
John B. Wong, MD;
Andreas E. Stuck, MD;
Hannes B. Staehelin, MD;
E. John Orav, PhD;
Anna Thoma, MD;
Douglas P. Kiel, MD;
Jana Henschkowski, MD
Arch Intern Med. 2009;169(6):551-561.
Background Antifracture efficacy with supplemental vitamin D has been questioned by recent trials.
Methods We performed a meta-analysis on the efficacy of oral supplemental vitamin D in preventing nonvertebral and hip fractures among older individuals ( 65 years). We included 12 double-blind randomized controlled trials (RCTs) for nonvertebral fractures (n = 42 279) and 8 RCTs for hip fractures (n = 40 886) comparing oral vitamin D, with or without calcium, with calcium or placebo. To incorporate adherence to treatment, we multiplied the dose by the percentage of adherence to estimate the mean received dose (dose x adherence) for each trial.
Results The pooled relative risk (RR) was 0.86 (95% confidence interval [CI], 0.77-0.96) for prevention of nonvertebral fractures and 0.91 (95% CI, 0.78-1.05) for the prevention of hip fractures, but with significant heterogeneity for both end points. Including all trials, antifracture efficacy increased significantly with a higher dose and higher achieved blood 25-hydroxyvitamin D levels for both end points. Consistently, pooling trials with a higher received dose of more than 400 IU/d resolved heterogeneity. For the higher dose, the pooled RR was 0.80 (95% CI, 0.72-0.89; n = 33 265 subjects from 9 trials) for nonvertebral fractures and 0.82 (95% CI, 0.69-0.97; n = 31 872 subjects from 5 trials) for hip fractures. The higher dose reduced nonvertebral fractures in community-dwelling individuals (–29%) and institutionalized older individuals (–15%), and its effect was independent of additional calcium supplementation.
Conclusion Nonvertebral fracture prevention with vitamin D is dose dependent, and a higher dose should reduce fractures by at least 20% for individuals aged 65 years or older.
Author Affiliations: Center on Aging and Mobility (Drs Bischoff-Ferrari and Henschkowski) and Department of Rheumatology and Institute of Physical Medicine (Drs Bischoff-Ferrari and Thoma), University of Zurich, University Hospital, Zurich, Switzerland; Departments of Nutrition (Drs Bischoff-Ferrari and Willett) and Biostatistics (Dr Orav), Harvard School of Public Health, Boston, Massachusetts; Division of Clinical Decision Making, Tufts Medical Center, Boston (Dr Wong); Department of Geriatrics and Rehabilitation, Zieglerspital, University of Bern, Bern, Switzerland (Drs Stuck and Henschkowski); Department of Geriatrics, University Hospital Basel, Basel, Switzerland (Dr Staehelin); and Division on Aging, Harvard Medical School, Boston (Dr Kiel).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Update: A 55-Year-Old Woman With Osteopenia
Mattson-DiCecca et al.
JAMA 2009;302:2023-2024.
FULL TEXT
Vitamin D: An Evidence-Based Review
Kulie et al.
J Am Board Fam Med 2009;22:698-706.
ABSTRACT
| FULL TEXT
Osteoporosis Disease Management: What Every Orthopaedic Surgeon Should Know
Dell et al.
JBJS 2009;91:79-86.
FULL TEXT
Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials
Bischoff-Ferrari et al.
BMJ 2009;339:b3692-b3692.
ABSTRACT
| FULL TEXT
Relationship Between Bone, Fracture, and Exercise: The Key Role of Vitamin D
Annweiler and Beauchet
Arch Intern Med 2009;169:1638-1638.
FULL TEXT
Relationship Between Bone, Fracture, and Exercise: The Key Role of Vitamin D--Reply
Bischoff-Ferrari et al.
Arch Intern Med 2009;169:1638-1638.
FULL TEXT
Epidemiology of Vitamin D Insufficiency and Cancer Mortality
PILZ et al.
Anticancer Res 2009;29:3699-3704.
ABSTRACT
| FULL TEXT
|
